Sunstone IPL (Intense Pulsed Light) for Hair Reduction

Inclusion Criteria: 1. Be willing to provide informed consent 2. Have a minimum of 24 hairs in each of the 2x4cm2 treatment area in axilla, bikini line, and leg, by visual inspection 3. Have a minimum of 10 hairs in the 1x2cm2 treatment area in face (upper lip), by visual inspection 4. Have a Fitzpatrick Skin Type I to V, with a melanin index less or equal to 553, as measured by Mexameter MX 18 in the designated treatment areas on face, axilla, bikini, and legs 5. Have natural body hair color that is dark blonde to black in the designated treatment areas 6. Are female subjects 18-65 years of age 7. Be either post-menopausal or surgically sterilized, or using a medically acceptable form of birth control (e.g., oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide or abstinence, etc.). 8. Be willing to participate in all scheduled study visits 9. Be willing to refrain from deliberate exposure to strong sun, products or procedures that would cause the skin to become darker in the designated treatment areas during the treatment phase 10. Be willing to refrain from the use of hair growth inhibitors/accelerators during the course of the study 11. Be willing to refrain from waxing, depilating or epilating of the face (upper lip), axilla, bikini line, and leg during the course of the study 12. Be willing to refrain from using aspirin or NSAIDS (e.g. acetaminophen, ibuprofen, etc.) within 5 days prior to and 5 days after treatment(s) Exclusion Criteria: 1. Have fewer than 8 qualifying treatment areas: 2 in face (upper lip), 2 in axilla, 2 on bikini line, 2 on leg) 2. Have a malignant or pre-malignant pigmented lesion in the area to be treated 3. Have scarring or infection of the area to be treated 4. Have a known history of photosensitivity or use of medication known to induce photosensitivity 5. Are currently pregnant or lactating or planning to become pregnant in the period of the study, per subject report 6. Are currently on a daily dose of aspirin or NSAIDS (e.g. acetaminophen, ibuprofen, etc.) or have taken aspirin and/or NSAID within 5 days prior to treatment that would reduce or increase the sensation of pain 7. Are not willing to abstain from the use of products or light exposure that would induce tanning in the treatment areas during the IPL treatment period (first 10 months) 8. Have a history of immunosuppressive disease (including HIV infection or AIDS) 9. Are on anticoagulative medication or have thromboembolic condition 10. Any form of isotretinoin (such as Accutane or Roaccutane etc.) in the last six months. 11. Have an active implantable device such as a pacemaker, neurostimulator or internal defibrillator 12. Have used waxing or other methods of root hair removal, or photo-epilation within 6 months prior to treatment 13. Have been exposed to strong sunlight or an artificial tanning machine within 4 weeks of enrolment 14. Have a tattoo(s), warts, moles, benign skin lesions, dark pigmented areas, permanent make-up etc. in the treatment areas. 15. Have eczema, psoriasis, lesions, open wounds or any skin affliction in the treatment areas 16. Have a history of keloid scar formation 17. Have a history of herpes outbreaks in the designated treatment areas 18. Have a history of photosensitive epilepsy 19. Have a condition related to hormonal changes like polycystic ovarian syndrome (PCOS) or taking drugs leading to hormonal changes resulting in excessive hair growth like hirsutism and idiopathic hirsutism 20. Have diabetes, or metabolic disease that affects hair growth 21. Taking immunosuppressive medication(s) 22. Have a disease related to photosensitivity, such as polymorphic light eruption (PMLE), solar urticaria, porphyria etc. 23. Have a history of skin cancer, including past basal cell carcinoma and/or squamous cell carcinoma in the designated treatment areas 24. Have a history of any radiation therapy in any of the designated treatment areas 25. Have a history of radiation therapy in non-treatment areas within 5 years 26. Have a history of chemotherapy 27. Have used hair growth inhibitors and/or accelerators within 6 months preceding enrolment 28. Have had laser or electrolysis treatment for the removal of hair in the treatment sites within the last year 29. Have natural body hair colors of white, grey, light to mid-blond, or red in the designated treatment areas 30. Have bleaching of the body hair in the designated treatment areas 6 months prior to study enrolment 31. Have shaved treatment areas within 7 days prior to study enrolment 32. Participating in other clinical studies prior to, or concurrently with this study, that could be deemed to interfere with full and complete participation in this study - as determined by the site Investigator. \-